Xarelto Claims Picked For Trial in 2017

From Orleans, LA comes the news that the first trial against the medication, Xarelto, will be held in early 2017. Others are due to follow. There is a huge portfolio of xarelto claims against the maker, Jannssen Pharmaceuticals Inc., and Bayer, which are still pending. The number of cases is nearly 14,000.

The plaintiffs allege that Xarelto caused blood to thin so much that it caused serious complications to patients. As there was no antidote to the blood thinner’s power, it caused serious harm. The first plaintiff to have his trial states that he was prescribed the medication for atrial fibrillation or Afib in early 2014. One month later he was in the hospital with bleeding so severe he required many blood transfusions.

He claims the makers mislead the public about the medication’s safety. They also failed to indicate the dangers of the drug to the medical community or to the US Food and Drug Administration. They only referenced certain results from clinical trials to get the pill on the market. The issues of the medication were not disclosed.

Xarelto was compared with its rival medication, Warfarin is also known generically as Coumadin. This medication requires routine blood tests and dietary restrictions of the patients who take it. Xarelto came out as being a much easier medication to take with as much safety and effectiveness as Warfarin.

There were tests done on the two and allegations were made against the readings taken of patients by Inratio. It was believed the readings showed patients in a control group taking too much Warfarin thereby casting a better light on the Xarelto. The FDA feels that any variations in the readings done by Inratio were too slight to skew the results for Xarelto. Originally, Xarelto was approved for DVT or deep vein thrombosis.

Eventually, Xarelto was introduced to the market to be a better, easier way of managing Warfarin patients. It seemed to be too ineffective at reducing the risks of DVT or stroke from atrial fibrillation. It helped manage the levels of Warfarin used. Too much of the Warfarin itself risked hemorrhages, and bleeding.

In their xarelto claims, plaintiffs made note of the lack of an antidote available to combat the excess Xarelto bleeding. With Warfarin, patients are taken care of with a vitamin K infusion. The treatment does not work on Xarelto, leaving it to be a risky medication. Plaintiffs further claim that the makers of Xarelto were irresponsible for claiming that Xarelto required no monitoring. Because it did not have a reversing agent, the opposite became true.

Xarelto came on the market with big expectations. In the first year on the market, it brought in close to $600 million. By the end of 2013, it yielded $2 billion. The future of the drug remains to be seen as these xarelto claims lawsuits come to trial.

How Bad Are Xarelto Adverse Effects

xarelto adverse effectsXarelto is Bayer’s multi billion dollar blood thinner marketed to prevent stroke and internal blood cuts. It might be a bestseller in the healthcare arena, but Xarelto adverse effects including unstoppable internal bleeding that may lead to death. For this and the lack of public warning, Bayer faces lawsuits filed by Xarelto victims.

Xarelto’s active ingredient is rivaroxaban (pronounced, Riv a Rox a ban). The drug is also composed of other inactive ingredients including hypromellose, lactose monohydrate, magnesium stearate, croscarmellose sodium, sodium lauryl sulfate and microcrystalline cellulose. So far, there is no generic form of this drug sold in the U.S market.

Xarelto is generally used to treat deep vein thrombosis, a serious blood clotting condition which could potentially lead to pulmonary embolism or the sudden blockage of major blood arteries in the lungs. Xarelto is also used for patients who have heart rhythm disorders to lower the risk of stroke which is caused by blood clotting.

Unfortunately, the likelihood of severe hemorrhage as a side effect from taking Xarelto is common. Hemorrhage is not just the common Xarelto adverse effects as liver dysfunction and abnormal blood clotting in organs were also cited by clinical studies on patients who used the drug. Xarelto can also be associated with indigestion, muscle spams, backache, urinary tract infection and abdominal pain. Studies also cited that Xarelto has some rare side effects including giant hives, hepatitis, abdominal bleeding and Steven-Johnson syndrome.

Despite the challenges of the FDA against Johnson and Johnson, the manufacturer still continues to promote the drug as safe and effective. J&J’s request for the FDA to approve Xarelto’s expanded uses have been declined three times.

Johnson & Johnsons wants to promote the drug for treating a certain condition based on a clinical conclusion from a study called ANCHOR. This specific usage might still be unapproved, but the company stated that doctors are already using it for cases associated with that study.

Xarelto belongs to a drug class known as Factor Xa inhibitors. Its side effects heighten if the drug is taken with other anticoagulant drugs. It is very necessary to talk to your doctor before using Xarelto and it shouldn’t be self-administered. Before using the drug, inform your doctor if you have; kidney or liver problem, another medical condition, has bleeding problems or is pregnant or wanting to become pregnant.

If you or a loved one suffered from the dangerous adverse effect of Xarelto, you can file a case against the manufacturer. A financial settlement may be made between the victim and J&J. You can file damages for reimbursements, for emotional trouble, medical expenses, lost wages and other burden results from Xarelto adverse effects.

As of the first half of 2015, there are already 2000 cases involved in Xarelto litigation.

Wound Complication From Using Xarelto

On the 2014’s PmLiVE Top Pharma List, Xarelto ranked as 23rd of the top 50 pharmaceutical products by global sales ranking. This ranking translates into big revenue for Bayer and Johnson & Johnson, the makers of the drug, both healthcare giants.

Drug Indication Using Xarelto:

•    Reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF). There are limited data on the relative effectiveness of XARELTO® (rivaroxaban) and warfarin in reducing the risk of stroke and systemic embolism when warfarin therapy is well controlled. Treatment of deep vein thrombosis (DVT). Treatment of pulmonary embolism (PE). Reduction in the risk of recurrence of DVT and of PE following initial 6 months treatment for DVT and/or PE
•    Xarelto is sometimes given to patients who went through total hip or total knee arhtroplasty to prevent pulmonary embolism or deep-vein thrombosis.
•    Many hospitals trust that rivaroxaban is a better alternative than low-molecular-weight heparin for thromboprophylaxis in lower limb arthroplasty. But in a study, there were fewer wound complications in low-molecular-weight heparin group compared to rivaroxaban.

Complication From Using Xarelto

There have been a number of adverse effects noted from using Xarelto. These include wound complications and infections. Wound complications associated with Xarelto’ usage for total hip or knee arthroplasty may include; infection, leakage, hematoma, chronic pain and prolonged drainage. Several studies support that these side effects likely  happen.

During 2015’s Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS),  complications associated with using Xarelto were discussed. A study called Rivaroxaban Use for Thrombosis Prophylaxis is an Independent Risk Factor for Early Periprosthetic Joint Infections was presented; citing the significant higher incidence of deep surgical infection in patients treated with Xarelto. At the same conference, physician Dr. Robert L. Barrack  of Washington University School of Medicine presented a review called “Aspirin and Mechanical Compression Sleeves are Best for Most.” to where he cited that prescribing aspirin and mechanical compression to patient should suffice for thromboprophylaxis. Dr. Barrack’s presentation created a debate whether the use of anticoagulant such as Xarelto is necessary of patients after surgery.

Xarelto is a blockbuster and is still a front liner in the blood thinner market with sales exceeding $1 billion. Furthermore, the manufacturers Johnson & Johnson’s and Bayer, announced that they are beginning the studies to find more uses of Xarelto. The manufacturers have already proposed a few extended uses of the drug but the FDA declined these.
Ellen Relkin, Weitz & Luxenberg  law firm cited that Xarelto presents 10-fold risk to patients using it. She said at that in a presentation at the American Academy of Orthopedic Surgeons, it was concluded that patients taking Xarelto experienced increased of deep surgical infection.

Now cases against Bayer and Johnson & Johnson’s are flooding across different states in the U.S. Thousands of complaints against both manufacturers are expected to arise soon as more patients come to realize the fatal adverse effects of Xarelto

Xarelto Side Effects and Uncontrolled Bleeding

Xarelto Side EffectsThe anticoagulant Xarelto may cause out of control bleeding, which is one of the harmful xarelto side effects that is leading some consumers and their family to find compensation with the help of lawyers and attorneys. Internal bleeding could be that dangerous that numerous deaths and of thousands of major bleeding incidents are found connected with an identical anticoagulant or blood thinner, Pradaxa. Up to now, there have been hundreds of Pradaxa legal cases filed by sufferers as well as their families. So if you or a loved one has had Xarelto and experienced from any of Xarelto side effects, you might consider filing a Xarelto lawsuit to get your right compensation.

Deaths Identified to Xarelto

Xarelto can be the same harmful path that Pradaxa has had. Numerous deaths and heavy bleeding instances were identified to Xarelto in 2012; even many more lawsuits are coming in this year also.

Harmful Thrombus or Blood Clots

Moreover, even though it is meant to prevent thrombus, the FDA (Food and drug administration) has received so many reviews of harmful thrombus by people who are using the drug.

How Can Xarelto Lead to Excessive Bleeding?

As the Xarelto is made to prevent the blood vessels from clots, there is much possibility that any traumas or injury can occur and even the smallest injury can be quite harmful. The anticoagulant operates by affecting certain proteins within the blood that normally begin the clots process and obstructs them.

It will take approximately 24 hours for that drug to become eliminated from the body. Older people face a more difficult time in eliminating the drug, and also the anti coagulation effect continues longer within their body. This makes elderly people at increased risk of possibly critical bleeding, particularly if they fall or hit their heads.

And the saddest part is, there’s no antidote, doctors do not have any method of preventing the bleeding immediately, and also the situation within the hospital could be terrible. Because the xarelto side effects mount, some doctors are increasing their cautious about utilizing Xarelto.

The drug may cause various kinds of bleeding, including:

  • Bleeding in the rectum
  • Intestinal or abdominal will bleed
  • Hemorrhaging
  • Bleeding within the brain

Patients who will have surgery must quit taking the drug minimum 24 hours prior to the procedure to prevent complications. Moreover, women that are pregnant are affected hemorrhaging while taking Xarelto.

According to several evidences, in comparison to warfarin, Xarelto also causes much more abdominal bleeding.

Lawsuits for Internal Bleeding

Lawsuits for Internal BleedingSince Xarelto internal bleeding is irreparable, people who’re stricken with this Xarelto side effect frequently end their journey to medical treatment. These treatments are always bit expensive and cause a lot of emotional trauma, particularly when the bleed condition is deadly.

The first sufferers filed the Xarelto law suits in June 2014 in U.S. In Philadelphia, Virginia Stuntebeck filed a suit against Bayer Company after she experienced severe internal bleeding induced with their blood thinner, Xarelto. After that in February 2013, she had to admit in hospital with severe gastrointestinal bleeding.

The complaint said, “As the producers and marketers of Xarelto, accused understood or must have known that Xarelto use was connected with irreversible will bleed”.

Another identical drug, Pradaxa, also triggered irrevocable bleeding and that is why the manufacturer, Boehringer Ingelheim compensated $650 million to cover thousands of cases.

On the other hand, Bayer claims that the drugs are safe.

Xarelto Blood Supervising Can Prevent Wrongful Death

Although, Xarelto continues to be marketed like an outstanding option to warfarin, using the drug manufacturers declaring that it’s simpler to utilize and doesn’t need regular blood supervising, there’s growing evidence that indicates the manufacturers might have been placing their wish to have more sales before patient safety by looking into making such broad claims.

The fact is bloods supervising while using Xarelto should be an essential method of reducing the chance of severe bleeding injuries, medications and wrongful death, potentially permitting doctors to recognize people who might be in the greatest chance of going through bleeding problems on Xarelto.

wrongful death
Actually, Xarelto supervising advice could have been notably useful for the patients while using new-generation anticoagulant rather than warfarin that has been the “go-to” anticoagulant for atrial fibrillation patients for many years, as there’s no antidote for Xarelto.

The blood thinner results of warfarin could be rapidly remedied in case of a hemorrhage, permitting doctors to assist the bloodstream to clot. However, there’s no such Xarelto antidote, frequently ended up with more serious bleeding injuries, as well as wrongful death.

According to a study published recently in the Journal of Cardiology, experts examined the possible advantages of determining coagulation function with Xarleto. After that experts supervised 84 patients out of the 136 who are taking Xarelto, examining prothrombin occasions (PTs) and plasma soluble fibrin (SF) levels during that time of treatment started or a minimum of two weeks after that.

The studies raise the question that why Bayer and Johnson & Johnson made the decision to promote Xarelto without proper blood monitoring strategies for doctors. Two probable conclusions are either they are unsuccessful to properly research and try out the drug before marketing it towards the public, or they placed their need to have elevated sales before consumer safety, by trying to acquire a benefit over warfarin that will convince doctors to change for their expensive optional anticoagulant.

Xarelto unwanted side effects can be accountable for so many severe bleeding injuries that may lead the patient to hospital stay as well as wrongful death. If immediate safety measures have been discovered to recommend Xarelto blood monitoring, a number of such fatal problems can be prevented.

Lawsuits for Xarelto Bleeding

Consequently from the drug manufacturer’s negligence to provide sufficient alerts and directions, financial compensation can be available if someone suffers from Xarleto bleeding:

  • Internal Bleeding
  • Rectal bleed
  • Brain Hemorrhage
  • Hemorrhagic Stroke
  • Wrongful Death

And you can get free consultation services and claim your lawsuit for the people throughout the United States who think that they or any of their family member or friend has faced such injury. So contact us today for more information and further help.

Status Conference Planned for Xarelto Class Action Settlements Lawyers

The judge handling the federal Xarelto class action Settlements related lawsuits will decide to share the entire process of moving the lawsuit ahead of the status conference. The U.S. Judicial Panel on Multidistrict Lawsuit commands consolidated pretrial proceedings in December 2014 for those Xarelto legal cases which are filed against Johnson & Johnson’s Janssen subsidiary and Bayer, presenting the these lawsuits before the U.S. district judge in federal court which is situated in the Eastern District of Louisiana.

You can contact us for getting any info regarding Xarelto class action settlements if you have experienced severe bleeding complications. We are here to answer your questions and to help those people who are filing lawsuit and finding settlements.

Xarelto Class Action Settlements

Xarelto claims should be reviewed

Drug manufacturers are dealing with a minimum of 220 defective drugs related lawsuits in federal multidistrict lawsuit including claims of life-threatening, severe bleeding complications and other injuries induced by unwanted side effects of the blood-thinner, Xarelto. Injured parties claim that the manufacturers unsuccessful both to properly warn of the perils of the drug and also to launch an antidote to reverse its anti-clots consequences.

Based on an idea for that status conference, the parties are required to talk about their difficulties with other several pretrial with the U.S. district judge, along with a possible tolling agreement (the contract typically accustomed to allow parties more hours to judge their claims’ authenticity or quantity of damages prior to the statute of restrictions runs), and also the drafting of the master complaint. They can also talk about the best method to coordinate the awaiting federal Xarelto claims with other cases which are also presently pending over the U.S.

It’s also estimated that the other small number of legal cases are going to be selected as bellwether cases included in the coordinated pretrial proceedings. These legal cases will be ready for early trial dates to assist the accused and litigants gauge how juries might react to testimony and proof throughout the entire class action settlement lawsuit.

Contact Us to Learn More About Xarelto Blood Thinner

In case you or your family member has encountered Xarelto Blood Thinner caused internal bleeding or any other severe side-effect you can contact us. We are here to assist you for getting the Xarelto settlements and we are able to help you to find a right attorney who is able to represent your lawsuit by asking proper compensation that you deserve.

Xarelto Blood Thinner and Pradaxa Drugs Companies Pay a Lot, Only to advertise

Within the last five months of 2013, the drug manufacturers invested nearly $20 million to advertise medicines hospitals and health care companies. One of the top 20 drugs listed by Business Insider that companies spend money most to advertise are Xarelto blood thinner and Pradaxa, both blood thinner are being claimed for many lawsuits.

You can contact us for getting any info regarding Xarelto or Pradaxa if you have experienced severe bleeding complications. We are here to answer your questions and to help those people who are filing lawsuit and finding settlements.

Xarelto Blood Thinner and Pradaxa

Most Advertised Drugs Pradaxa & Xarelto Blood Thinners

Serious unwanted side effects have already been reported after using the blood thinners like Xarelto and Pradaxa, and so many legal cases happen to be filed by proclaiming that, these drug makers are unsuccessful to warn t properly to the medical community and customers of the hazards connected using the drugs. Litigants have claimed the drug manufacturers are unsuccessful to reveal the fatal risks connected with the utilization of Xarelto and Pradaxa, include severe bleeding issues.

Based on the post by Business Insider, these drugs companies spend the money for most to advertise, Xarelto and Pradaxa are sixth and thirteenth in rank, correspondingly. The content also indicates that competition is the reason for drug companies’ marketing investing. Approximately nine items out of the twenty listed stood a competitor dealing with with exactly the same condition also positioned in the top 20. Anti-clots Drugs Eliquis and Brilinta have been also listed, with a rating of second and third correspondingly.

Contact Us to Learn More About Xarelto Blood Thinner And Pradaxa

In case you or your family member has encountered Xarelto Blood Thinner caused internal bleeding or any other severe side-effect you can contact us. We are here to assist you for getting the Xarelto settlements and we are able to help you to find a right attorney who is able to represent your lawsuit by asking proper compensation that you deserve.